| | | Be it enacted by the People of the State of Maine as follows: |
|
| | | Sec. 1. 22 MRSA §2699 is enacted to read: |
|
| | | §2699.__Advertising and promotional expenses |
|
| | | A manufacturer or labeler of prescription drugs dispensed in | | this State that employs, directs or utilizes marketing | | representatives in this State shall report the costs of | | advertising and promotional expenses for prescription drugs in | | this State as provided in this section. For the purposes of | | this section, "manufacturer" and "labeler" have the same | | meanings as provided in section 2697, subsection 1. |
|
| | | 1.__Purposes.__Advertising and promotional expenses for | | prescription drugs in this State must be reported to the Maine | | Health Data Organization, established in chapter 1683, for the | | purposes of assisting this State in its role as a purchaser of | | prescription drugs and an administrator of prescription drug | | programs, enabling this State to determine the scope of | | prescription drug advertising and promotional expenses and | | their effect on the cost, utilization and delivery of health | | care services and furthering the role of this State as | | guardian of the public interest. |
|
| | | 2.__Manner of reporting.__By July 1st each year a | | manufacturer or labeler of prescription drugs that directly or | | indirectly distributes prescription drugs for dispensation to | | residents of this State shall file an annual report with the | | Maine Health Data Organization in the form and manner provided | | by the organization.__The report must be accompanied by | | payment of a fee, as set by the organization in rule, to | | support the work of the organization under this section. |
|
| | | 3.__Content of annual report by manufacturer or labeler.__ | | The annual report filed under subsection 2 must include the | | following information as it pertains to advertising and | | promotional activities conducted within this State: |
|
| | | A.__All expenses associated with advertising, marketing | | and direct promotion of prescription drugs through radio, | | television, magazines, newspapers, direct mail and | | telephone communications as they pertain to residents of | | this State; |
|
| | | B.__With regard to all persons and entities licensed to | | provide health care in this State, including health care | | professionals and persons employed by them in this State, | | carriers licensed under Title 24 or Title 24-A, health plans | | and benefits managers, pharmacies, hospitals, nursing | | facilities, clinics and other entities licensed to provide |
|
|